<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34881374</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-6065</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The Lancet regional health. Western Pacific</Title><ISOAbbreviation>Lancet Reg Health West Pac</ISOAbbreviation></Journal><ArticleTitle>Inactivated enterovirus A71 vaccines and moving forward.</ArticleTitle><Pagination><StartPage>100292</StartPage><MedlinePgn>100292</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100292</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.lanwpc.2021.100292</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shimizu</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Virology II, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayama-shi, 208-0011 Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Reg Health West Pac</MedlineTA><NlmUniqueID>101774968</NlmUniqueID><ISSNLinking>2666-6065</ISSNLinking></MedlineJournalInfo><CoiStatement>Hiroyuki Shimizu has received a research grant from the Japan Agency for Medical Research and Development, Grant Number JP21fk0108084.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>9</Day><Hour>7</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>10</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34881374</ArticleId><ArticleId IdType="pmc">PMC8551814</ArticleId><ArticleId IdType="doi">10.1016/j.lanwpc.2021.100292</ArticleId><ArticleId IdType="pii">S2666-6065(21)00201-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vidor E. In: Plotkin's Vaccines. Plotkin S, Orenstein W, Offit P., Edwards KM, editors. Elsevier; Philadelphia: 2018. Poliovirus vaccine-inactivated; pp. 841&#x2013;865.</Citation></Reference><Reference><Citation>Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis. 2014;14:308&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu H, Nakashima K. Surveillance of hand, foot, and mouth disease for a vaccine. Lancet Infect Dis. 2014;14:262&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pubmed">24485992</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao QY, Wang Y, Bian L, Xu M, Liang Z. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD) Expert Rev Vaccines. 2016;15:599&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="pubmed">26732723</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Gao F, Wang Y, Li J, Zhang Y, Lv H. Immunogenicity and safety of inactivated enterovirus A71 vaccines in children aged 6-35 months in China: a non-inferiority, randomised controlled trial. The Lancet Regional Health-Western Pacific. 2021 doi: 10.1016/j.lanwpc.2021.100284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanwpc.2021.100284</ArticleId><ArticleId IdType="pmc">PMC8579145</ArticleId><ArticleId IdType="pubmed">34881371</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Shi Y, Miao L, Zhang C, Liu Y. Molecular epidemiology and recombination of Enterovirus A71 in mainland China from 1987 to 2017. Int Microbiol. 2021;24:291&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7895512</ArticleId><ArticleId IdType="pubmed">33608776</ArticleId></ArticleIdList></Reference><Reference><Citation>Puenpa J, Wanlapakorn N, Vongpunsawad S, Poovorawan Y. The history of enterovirus A71 outbreaks and molecular epidemiology in the Asia-Pacific region. J Biomed Sci. 2019;26:75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6798416</ArticleId><ArticleId IdType="pubmed">31627753</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng H, Yi L, Chen X, Zhou H, Zheng H, Lu J. Emergence of a non vaccine-cognate enterovirus A71 genotype C1 in mainland China. J Infect. 2021;82:407&#x2013;413.</Citation><ArticleIdList><ArticleId IdType="pubmed">33373653</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang KA, Huang PN, Huang YC, Yang SL, Tsao KC, Chiu CH. Emergence of genotype C1 Enterovirus A71 and its link with antigenic variation of virus in Taiwan. PLoS Pathog. 2020;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7521691</ArticleId><ArticleId IdType="pubmed">32936838</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoa-Tran TN, Dao ATH, Nguyen AT, Kataoka C, Takemura T, Pham CH. Coxsackieviruses A6 and A16 associated with hand, foot, and mouth disease in Vietnam, 2008-2017: essential information for rational vaccine design. Vaccine. 2020;38:8273&#x2013;8285.</Citation><ArticleIdList><ArticleId IdType="pubmed">33223308</ArticleId></ArticleIdList></Reference><Reference><Citation>Feder HM, Bennett N, Modlin JF. Atypical hand, foot, and mouth disease: a vesiculobullous eruption caused by Coxsackie virus A6. Lancet Infect Dis. 2014;14:83&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">24287184</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>